Dependence on UltraMIST® product line
Most revenue comes from one platform, so demand or competitive pressure on that product would affect results materially.
- Scope
- UltraMIST® systems and disposables
- Materiality
- high
SANUWAVE Health, Inc.
SANUWAVE Health, Inc. develops and commercializes non-invasive shockwave and acoustic wave therapy systems used in wound care and other medical applications. The company is based in the United States and operates as a single-segment medical device business with sales in the U.S. and selected international markets.
13,4 %
77,1 %
26,8 %
+35,0 %
1.38
1.05
| % | |
|---|---|
| UltraMIST® systems | 55% Capital equipment used to deliver non-contact wound therapy in clinical settings. |
| UltraMIST® disposables | 40% Recurring consumables used with UltraMIST® systems during treatment sessions. |
| Applicators and accessories | 3% Replacement parts and accessories used with the therapy platform. |
| Other medical device products and services | 2% Smaller revenue streams from related device sales and support activities. |
SANUWAVE sells primarily to healthcare providers that treat chronic and acute wounds, including hospitals, outpatient...
- Hospitals and health systemsprimary
Buy UltraMIST® systems and consumables for inpatient and outpatient wound care programs.
- Outpatient wound care centersprimary
Purchase systems and disposables for recurring treatment of chronic wounds.
- Physician practicessecondary
Use the platform for office-based wound treatment and follow-on consumables.
- Distributors and channel partnerssecondary
Buy and resell systems and supplies into clinical end markets.
The company generates revenue primarily in the United States, with additional sales in Europe, Canada, the Middle East,...
- •Revenue is generated primarily in the United States
- •International sales span Europe, Canada, the Middle East and Asia
- •Significant assets are located in the United States
- •Significant expenses are generated in the United States
- •Foreign sales add channel and regulatory complexity
SANUWAVE’s strategy centers on expanding adoption of UltraMIST® systems while increasing recurring disposable sales...
01
Expand UltraMIST® adoptionmedium-term
System placements create a recurring consumables stream and deepen customer relationships.
02
Grow disposable pull-throughshort-term
Consumables drive repeat revenue after the initial system sale.
03
Maintain capital flexibilityshort-term
A medical device commercializer needs liquidity to fund operations and growth.
The business depends heavily on continued clinical adoption of UltraMIST® and on the company’s ability to support sales...
Liquidity and refinancing risk
Commercialization requires ongoing capital, and debt maturities can pressure flexibility if refinancing is delayed or costly.
- Scope
- Debt and working capital
- Materiality
- high
Regulatory and reimbursement risk
Medical device sales depend on approvals, clinical acceptance, and payer economics in wound care.
- Scope
- U.S. and international healthcare markets
- Materiality
- high
Product liability and litigation
Device companies can face claims tied to product performance, safety, or commercial disputes.
- Scope
- Medical device operations
- Materiality
- medium
Foreign market execution risk
International sales require distributors, local compliance, and market-specific commercialization efforts.
- Scope
- Europe, Canada, Middle East, Asia
- Materiality
- medium
Revenue recognition for systems and disposables
Mix between capital equipment and consumables
Derivative liabilities at fair value
Net income and non-GAAP adjustments
Debt issuance costs and discounts
Non-cash financing-related expense
Stock-based compensation
Operating expenses and adjusted EBITDA
InnovAge Holding Corp.
INNV · Services-Health Services
SYNLOGIC, INC.
SYBX · Pharmaceutical Preparations
VisionWave Holdings, Inc.
VWAV · Services-Prepackaged Software
HERON THERAPEUTICS, INC. /DE/
HRTX · Pharmaceutical Preparations
Heron Therapeutics is a U.S.-based commercial-stage biotechnology company focused on acute care and oncology supportive care products.
Medicale Corp.
MCLE · Services-Health Services
Unicycive Therapeutics, Inc.
UNCY · Pharmaceutical Preparations
: 29.4.2026